ACEA Biosciences goes live with exhaustive library of NovoCyte papers spanning dozens of different applications
With the 2014 release of its NovoCyte flow cytometer ACEA Biosciences delivered a highly innovative instrument at an extremely competitive price point. In the ensuing three years features such as automated fluidics protocols, a highly flexible and upgradable optical platform, autosampling, direct volumetric cell counting, and the industry leading NovoExpress software have enabled the NovoCyte to quickly gain broad market penetrance. These instruments are now being used for diverse applications in hundreds of academic, government, industrial, and CRO laboratories worldwide. Due to NovoCyte’s phenomenal rate of adoption, a steady flow of peer-reviewed research articles employing this instrument are now being published.
As a tool for viewing these real world examples of NovoCyte’s utility for specific applications, today ACEA launched a comprehensive and searchable online library. “This collection of publications, which can be queried based on application, will help prospective and existing NovoCyte users readily find information and protocols,” stated Rene Nunez, ACEA’s Associate Director of Marketing. To view the new library, click here.
About ACEA Biosciences
Founded in 2002, ACEA Biosciences is a pioneer in the development and commercialization of high performance, cutting edge cell analysis platforms for life science research. ACEA’s xCELLigence® impedance-based, label-free, real-time cell analysis instruments and NovoCyte® flow cytometer are used for dozens of different applications within industrial and academic research laboratories.
For further information please contact:
ACEA Biosciences, Inc.
Dr. Jeff Xue
Phone: 1-858-724-0928, x3075